Cinchona Officinalis, Cocculus Indicus, Arnica Montana, Coffea Cruda, Tabacum
Generic Name: cinchona officinalis, cocculus indicus, arnica montana, coffea cruda, tabacum
Dosage form: POWDER. Active ingredients: ANAMIRTA COCCULUS SEED (12 [hp_X]/12kg); ARABICA COFFEE BEAN (6 [hp_X]/12kg); ARNICA MONTANA (6 [hp_X]/12kg); CINCHONA OFFICINALIS BARK (12 [hp_X]/12kg); TOBACCO LEAF (6 [hp_X]/12kg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: POWDER. Active ingredients: ANAMIRTA COCCULUS SEED (12 [hp_X]/12kg); ARABICA COFFEE BEAN (6 [hp_X]/12kg); ARNICA MONTANA (6 [hp_X]/12kg); CINCHONA OFFICINALIS BARK (12 [hp_X]/12kg); TOBACCO LEAF (6 [hp_X]/12kg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as powder.
Related Medications
Carbo Vegetabilis, Chamomilla, Foeniculum Vulgare, Lycopodium, Nux Moschata, Raphanus Sativus, Zingiber Officinale, Kali Muriaticum, Magnesia Phosphorica, Natrum Phosphoricum
carbo vegetabilis, chamomilla, foeniculum vulgare, lycopodium, nux moschata, raphanus sativus, zingiber officinale, kali muriaticum, magnesia phosphorica, natrum phosphoricum
Non-Standardized Plant Allergenic Extract [EPC]
Purpose Purpose Abdominal pain due to excessive gas Abdominal discomfort with associated irritability Indigestion Excessive gas Nausea, diarrhea Abdominal distension Stomach hyperacidity Abdominal inflammation Colic type abdominal pain Stomach hyperacidity Purpose
Denosumab-qbde
denosumab-qbde
RANK Ligand Inhibitor [EPC]
11 DESCRIPTION Denosumab-qbde is a human IgG2 monoclonal antibody with affinity and specificity for human RANKL (receptor activator of nuclear factor kappa-B ligand). Denosumab-qbde has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells. Enoby (denosumab-qbde) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to pale yellow solution for subcutaneous use.
Folic Acid
folic acid
Folic acid is a B complex vitamin containing pteridine linked to para-aminobenzoic acid joined to glutamic acid, available as an oral solution for the treatment of megaloblastic anemias due to folic acid deficiency.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.